KVUE vs TGT
KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories. TGT: A general merchandise retailer offering design-led, discounted apparel, home goods, and essentials across over 1,900 stores and digital channels, with stores fulfilling 97% of sales.
Side-by-side fundamentals
| Metric | KVUE | TGT | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $19.18 | $132.27 | |
| Market cap as of 2026-07-10 | $36.8B | $61.1B | |
| P/E as of 2026-07-10 | 22.70 | 17.72 | TGT lower |
| PEG as of 2026-07-10 | 2.72 | 2.90 | KVUE lower |
| Net margin as of 2026-07-10 | +10.6% | +3.2% | KVUE higher |
| Gross margin as of 2026-07-10 | +58.9% | +28.1% | KVUE higher |
| Operating margin as of 2026-07-10 | +17.1% | +4.5% | KVUE higher |
| ROE as of 2026-07-10 | +15.2% | +21.7% | TGT higher |
| ROA as of 2026-07-10 | +6.0% | +5.9% | KVUE higher |
| Debt / equity as of 2026-07-10 | 0.82 | 0.94 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-10 | -0.1% | +0.5% | TGT higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | -1.3% | KVUE higher |
| Dividend yield as of 2026-07-10 | +4.3% | +3.5% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 3 | 5 | TGT higher |
| Beta as of 2026-07-10 | 0.45 | 0.98 | |
| 1-year return as of 2026-07-09 close | -6.8% | +29.1% | TGT higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.